GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Mitsubishi Chemical Group Corp (OTCPK:MTLHF) » Definitions » Sale Of Business

MTLHF (Mitsubishi Chemical Group) Sale Of Business : $376 Mil (TTM As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mitsubishi Chemical Group Sale Of Business?

Mitsubishi Chemical Group's sale of business for the three months ended in Sep. 2024 was $98 Mil. It means Mitsubishi Chemical Group gained $98 Mil from selling business. Mitsubishi Chemical Group's sale of business for the trailing twelve months (TTM) ended in Sep. 2024 was $376 Mil.

Compared with last quarter ($0 Mil in Jun. 2024 ), Mitsubishi Chemical Group gained more money from selling business in Sep. 2024 ($98 Mil).

Mitsubishi Chemical Group Sale Of Business Historical Data

The historical data trend for Mitsubishi Chemical Group's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mitsubishi Chemical Group Sale Of Business Chart

Mitsubishi Chemical Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.34 43.86 690.70 88.03 304.60

Mitsubishi Chemical Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.38 283.64 -4.93 - 97.78

Mitsubishi Chemical Group Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $376 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mitsubishi Chemical Group Sale Of Business Related Terms

Thank you for viewing the detailed overview of Mitsubishi Chemical Group's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Mitsubishi Chemical Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Mitsubishi Chemical Group Corp (OTCPK:MTLHF) » Definitions » Sale Of Business
Comparable Companies
TSE:5201 TSE:6988 TSE:4185 TSE:4183 TSE:4403 TSE:4613 TSE:4182 TSE:4088 TSE:4202 TSE:4203 LIN XPAR:AI SHW APD ECL XSWX:SIKA BOM:500820 XSWX:GIVN PPG SHSE:600309
Traded in Other Exchanges
MTLHY:USA 4188:Japan M3C0:Germany M3C:Germany M3C:Germany
Address
1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-8251
Website
https://www.mcgc.com
Mitsubishi Chemical Group Corp is a holdings company, which manufactures and sells chemicals, plastics, and pharmaceuticals. It organizes itself into three segments based on product. The Industrial Materials segment, which generates the majority of revenue, sells chemicals and polymers, including industrial gases, petrochemicals, thermoplastics, polyethylene, and polypropylene. The Performance Products segment sells electronics and designed materials, including LED lighting and equipment, specialty chemicals, polyester and industrial films, and fibers. The Health Care segment sells pharmaceuticals to treat autoimmune diseases, diabetes and kidney diseases, central nervous system treatments, and vaccines. The majority of revenue comes from Japan.